The following drug companies made headlines in the past two weeks.
- Democratic lawmakers launch investigation into high MS drug prices
House Democrats are investigating seven drug companies in relation to the high price of multiple sclerosis drugs in the U.S. - Mylan finalizes $465 million settlement with DOJ over EpiPen rebates
Mylan on Thursday finalized a $465 million settlement with the federal government over accusations the Canonsburg, Pa.-based drugmaker improperly classified EpiPens as a generic drug to overcharge Medicaid.
- CDC: Yellow fever vaccine out of stock
The supply of Sanofi Pasteur's yellow fever vaccine — the only such immunization licensed in the U.S. — is completely depleted and will remain out of stock until mid-2018, according to the CDC.
- Amneal Pharma recalls liquid anxiety drug over dropper defects: 4 things to know
Amneal Pharmaceuticals on Aug. 14 issued a voluntary recall of its Lorazepam Oral Concentrate solution over issues with the droppers packaged with the medication.
- Nationwide recall issued for all PharmaTech liquid drugs
Three drug distributors on Aug. 10 issued nationwide recalls for all liquid drugs manufactured by PharmaTech, an Athens, Ga.-based drugmaker.
- Stool softeners recalled over bacterial contamination
Livonia, Mich.-based Rugby Laboratories is recalling its Diocto liquid and Diocto syrup stool softener products over a risk of bacterial contamination.
- Drugmaker raises price of common diarrhea drug by 430%: 4 things to know
Columbus, Ohio-based West-Ward Pharmaceuticals — the U.S. subsidiary of London-based Hikma Pharmaceuticals — increased the price of a common diarrhea drug by 430 percent.
More articles on supply chain:
7 must-reads for supply chain leaders this week
Mylan finalizes $465 million settlement with DOJ over EpiPen rebates
CDC: Yellow fever vaccine out of stock